Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EYA3 | Q99504 | 8/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.57 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | THRA | P10827 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.48 |
| ▸ | TTR | P02766 | 2/20 | 0.48 |
| ▸ | PGR | P06401 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6480569 | 0.86 | CYP2C19 (0.61) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL6737999 | 0.83 | EYA3 (0.71) | EYA3CYP2C19CYP2C9GABRA1GABRB1 | |
| SCHEMBL6574630 | 0.82 | GABRA1 (0.51) | EYA3CYP2C19CYP2C9GABRA1GABRB1 | |
| SCHEMBL3219908 | 0.82 | EYA3 (1.00) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL6482824 | 0.81 | THRA (0.72) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL27586552 | 0.78 | CYP2C19 (0.64) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL28245008 | 0.78 | CYP2C19 (0.79) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL8994710 | 0.77 | CYP2C19 (1.00) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL28245012 | 0.75 | CYP2C19 (0.79) | EYA3CYP2C19CYP2C9THRBTHRA | |
| SCHEMBL6482244 | 0.73 | THRA (0.51) | EYA3CYP2C19CYP2C9THRBTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050065208-A1 | Benzofuranes and their use in the treatment of atrial fibrillation | KARO BIO AB (SE) | 2005-03-24 | — | — | US | claimed |
| CN-1533274-A | Benzofuranes and their use in treatment of artrial fibrillation | �����ɷ� | 2004-09-29 | — | — | CN | claimed |
| EP-1408958-A1 | BENZOFURANES AND THEIR USE IN THE TREATMENT OF ATRIAL FIBRILLATION | KARO BIO AB (SE) | 2004-04-21 | — | — | EP | claimed |
| WO-2003009839-A1 | BENZOFURANES AND THEIR USE IN THE TREATMENT OF ATRIAL FIBRILLATION | KARO BIO AB (SE) | 2003-02-06 | — | — | WO | claimed |
| US-20050065208-A1 | Benzofuranes and their use in the treatment of atrial fibrillation | KARO BIO AB (SE) | 2005-03-24 | — | — | US | disclosed |
| CN-1533274-A | Benzofuranes and their use in treatment of artrial fibrillation | �����ɷ� | 2004-09-29 | — | — | CN | disclosed |
| EP-1408958-A1 | BENZOFURANES AND THEIR USE IN THE TREATMENT OF ATRIAL FIBRILLATION | KARO BIO AB (SE) | 2004-04-21 | — | — | EP | disclosed |
| WO-2003009839-A1 | BENZOFURANES AND THEIR USE IN THE TREATMENT OF ATRIAL FIBRILLATION | KARO BIO AB (SE) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065208-A1 | Benzofuranes and their use in the treatment of atrial fibrillation | KCNH1, KCNJ2, KCNQ2 | EYA3 3572/4885CYP2C19 240/4885CYP2C9 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.